These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Determination of plasma drug concentration and bioavailability of indomethacin controlled release capsule by high performance liquid chromatography].
    Author: Zhang D, Zeng J, Bianba-Cangjue, Jiang X.
    Journal: Se Pu; 1997 Nov; 15(6):515-7. PubMed ID: 15739336.
    Abstract:
    A simple, rapid, sensitive and accurate reversed-phase high performance liquid chromatographic (RP-HPLC) method for the determination of indomethacin in plasma is established. To 1 mL of plasma were added 200 microL of amobarbitone solution (internal standard; 1 g/L), 100 microL of phosphate buffer solution (pH 7.0), 100-150 mg of sodium chloride and 2.5 mL of ethyl acetate. The mixture was vortex-mixed for 10 min and centrifuged at 3000 r/min for 5 min. The organic layer was evaporated to dryness at 50 degrees C on water-bath and the residue was dissolved in methanol (100 microL). A 20 microL portion of the resulting solution was analysed by HPLC on a column (25 cm x 4.6 mm) of micro-Bondapak C18 (10 microm) with 76% methanol in 0.035 mol/L phosphoric acid (pH 5.5) aq-solution as mobile phase (1 mL/min) and UV detection at 260 nm. The column temperature was 30 degrees C. Within the range of 0.125-50 mg/L of indomethacin there was a good linearity (r = 0.9996). The mean recovery of indomethacin was 100.4%. The detectable limit was 62.5 microg/L (S/N = 3:1). The within day and day-to-day RSD were less than 5% at three drug levels. This method has been used to determine plasma drug concentration and bioavailability of indomethacin controlled release capsule for healthy volunteers.
    [Abstract] [Full Text] [Related] [New Search]